Related references
Note: Only part of the references are listed.Androgen Deprivation Therapy and the Risk of Dementia in Patients With Prostate Cancer
Farzin Khosrow-Khavar et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Lifestyle guidelines for managing adverse effects on bone health and body composition in men treated with androgen deprivation therapy for prostate cancer: an update
P. J. Owen et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2017)
Association Between Androgen Deprivation Therapy and Risk of Dementia
Kevin T. Nead et al.
JAMA ONCOLOGY (2017)
A Randomised Comparison Evaluating Changes in Bone Mineral Density in Advanced Prostate Cancer: Luteinising Hormone-releasing Hormone Agonists Versus Transdermal Oestradiol
Ruth E. Langley et al.
EUROPEAN UROLOGY (2016)
Androgen deprivation therapy is associated with diabetes: Evidence from meta-analysis
Huimin Wang et al.
JOURNAL OF DIABETES INVESTIGATION (2016)
Androgen deprivation therapy and cardiovascular disease: what is the linking mechanism?
Piotr Zareba et al.
THERAPEUTIC ADVANCES IN UROLOGY (2016)
PSHREG: A SAS macro for proportional and nonproportional subdistribution hazards regression
Maria Kohl et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2015)
Risk and Timing of Cardiovascular Disease After Androgen-Deprivation Therapy in Men With Prostate Cancer
Sean O'Farrell et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Androgen-deprivation therapy and bone loss in prostate cancer patients: a clinical review
Marc Bienz et al.
BONEKEY REPORTS (2015)
Androgen-deprivation Therapy in Treatment of Prostate Cancer and Risk of Myocardial Infarction and Stroke: A Nationwide Danish Population-based Cohort Study
Christina G. Jespersen et al.
EUROPEAN UROLOGY (2014)
Bone complications among prostate cancer survivors: long-term follow-up from the prostate cancer outcomes study
A. K. Morgans et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2014)
Advanced Prostate Cancer Treated with Intermittent or Continuous Androgen Deprivation in the Randomised FinnProstate Study VII: Quality of Life and Adverse Effects
Arto J. Salonen et al.
EUROPEAN UROLOGY (2013)
Androgen Deprivation Therapy and Risk of Acute Kidney Injury in Patients With Prostate Cancer
Francesco Lapi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Androgen Deprivation Therapy Impact on Quality of Life and Cardiovascular Health, Monitoring Therapeutic Replacement
Landon W. Trost et al.
JOURNAL OF SEXUAL MEDICINE (2013)
Intermittent hormonal therapy in the treatment of metastatic prostate cancer: a randomized trial
Nicolas Mottet et al.
BJU INTERNATIONAL (2012)
Timing of androgen deprivation therapy use and fracture risk among elderly men with prostate cancer in the United States
Jennifer L. Beebe-Dimmer et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2012)
Association of Androgen Deprivation Therapy With Cardiovascular Death in Patients With Prostate Cancer A Meta-analysis of Randomized Trials
Paul L. Nguyen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy: Observational Study of Veterans With Prostate Cancer
Nancy L. Keating et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Risk of colorectal cancer in men on long-term androgen deprivation therapy for prostate cancer
Silke Gillessen et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Reimbursement Policy and Androgen-Deprivation Therapy for Prostate Cancer.
Vahakn B. Shahinian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Metabolic sequelae associated with androgen deprivation therapy for prostate cancer
Jason E. Faris et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2010)
Review of Major Adverse Effects of Androgen-deprivation Therapy in Men With Prostate Cancer
Lockwood G. Taylor et al.
CANCER (2009)
Impact of Androgen Deprivation Therapy on Cardiovascular Disease and Diabetes
Shabbir M. H. Alibhai et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer
Christopher S. Saigal et al.
CANCER (2007)
Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer
Nancy L. Keating et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Risk of fracture after androgen deprivation for prostate cancer
VB Shahinian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Development of a comorbidity index using physician claims data
CN Klabunde et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2000)
Share Paper
